Ge Hlthcare Drug Patent Portfolio
Ge Hlthcare owns 1 orange book drug protected by 6 US patents Given below is the list of Ge Hlthcare's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9687571 | Stabilization of radiopharmaceutical compositions using ascorbic acid | 01 Nov, 2032 | Active |
| US8936777 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | 30 Jun, 2031 | Active |
| US9603951 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | 02 May, 2031 | Active |
| US8226929 | Contrast agents for myocardial perfusion imaging | 21 Jun, 2028 | Active |
| US7344702 | Contrast agents for myocardial perfusion imaging | 26 May, 2026 | Active |
| US9161997 | Contrast agents for myocardial perfusion imaging | 04 Feb, 2026 | Active |
Ge Hlthcare's Family Patents
Ge Hlthcare Drug List
Given below is the complete list of Ge Hlthcare's drugs and the patents protecting them.
1. Flyrcado
Flyrcado is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9687571 | Stabilization of radiopharmaceutical compositions using ascorbic acid |
01 Nov, 2032
(7 years from now)
| Active |
| US8936777 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
30 Jun, 2031
(6 years from now)
| Active |
| US9603951 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
02 May, 2031
(6 years from now)
| Active |
| US8226929 | Contrast agents for myocardial perfusion imaging |
21 Jun, 2028
(3 years from now)
| Active |
| US7344702 | Contrast agents for myocardial perfusion imaging |
26 May, 2026
(1 year, 5 months from now)
| Active |
| US9161997 | Contrast agents for myocardial perfusion imaging |
04 Feb, 2026
(1 year, 1 month from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flyrcado's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List